Mark S. Levine has an estimated net worth of $12.2 Million. This is based on reported shares across multiple companies, which include Immunovant, Inc., Flexion Therapeutics Inc, Minerva Neurosciences, Inc., and 908 Devices Inc..

2017 was Mark S. Levine's most active year for acquiring shares with 4 total transactions. Mark S. Levine's most active month to acquire stocks was the month of February. 2024 was Mark S. Levine's most active year for disposing of shares, totalling 15 transactions. Mark S. Levine's most active month to dispose stocks was the month of December. 2017 saw Mark S. Levine paying a total of $173,370.00 for 160,000 shares, this is the most they've acquired in one year. In 2021 Mark S. Levine cashed out on 356,093 shares for a total of $1,236,083.02, their largest year based on trade value.